Effect of CXCR7 receptor overexpression on U2932 DLBCL cells.
- María José Moreno (5420918)
- Alberto Gallardo (1943311)
- Silvana Novelli (5420921)
- Ana Mozos (5420939)
- Marc Aragó (5420927)
- Miguel Ángel Pavón (5420936)
- María Virtudes Céspedes (5420915)
- Víctor Pallarès (5420942)
- Aïda Falgàs (5420924)
- Miguel Alcoceba (3805117)
- Oscar Blanco (2286286)
- Marcos Gonzalez-Díaz (5420933)
- Jorge Sierra (52100)
- Ramon Mangues (5420930)
- Isolda Casanova (1800304)
Publication date
June 2018
DOIAbstract
<p>(A) Quantification of CXCR7 expression by flow cytometry, in the total population of transfected U2932-CXCR7 and U2932-control cells or after measurements restricted only to GFP+ cells. Values are expressed as mean fluorescence intensity (MFI) (B) Proliferation rate as measured by cell density (number of cells/ml) over time in GFP+ U2932-CXCR7 or U2932-control cells (C) Percentage of cell viability, measured by Trypan Blue staining, over time for GFP+ U2932-CXCR7 or U2932-control cells (D) Antitumor effect, expressed as percentage of cell viability respect to control cells, after 48h exposure of GFP+ U2932-CXCR7, or U2932-control cells, to 10μM mafosfamide or 1μM doxorubicin. <i>** p<0</i>,<i>01; * p<0</i>,<i>05</i>.</p
Add to ORKG